ORGAN ON A CHIP MARKET ANALYSIS

Organ On A Chip Market, By Products & Service (Products and Services), By Application (Toxicology Testing, Disease Modeling/Physiological model development, Drug discovery, Stem cell research, and Tissue regeneration and regenerative medicines), By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jan 2025
Code : CMI49
Pages :120
Formats :
Excel and PDF
Industry : Medical Devices

Organ On A Chip Market Size and Trends

The Global Organ-on-a-Chip Market is estimated to be valued at USD 155.3 Mn in 2025 and is expected to reach USD 1,211.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 34.1% from 2025 to 2032.

Key Takeaways of the Organ-on-a-Chip Market:

In terms of products & service, the products segment is expected to contribute the highest share of the market with 52.1% in 2025.
In terms of application, the toxicology testing segment is expected to contribute the highest share of the market with 33.4% in 2025.
In terms of end user, the pharmaceutical and biotechnology companies segment is expected to contribute the highest share of the market with 43.4% in 2025.
North America is expected to top the market with 37.4% share, followed by Asia pacific with 27.4% share in 2025.

Market Overview:

The increasing need for alternative methods for drug screening and the growing focus on developing organ-level models of disease pathology are major factors expected to drive the demand for organ-on-a-chip devices. Furthermore, increasing collaborations between research academics and market players to develop more sophisticated organ-on-a-chip platforms will further augment the market growth. Availability of funding from private and public organizations for research on microfluidic devices is also expected to propel the organ-on-a-chip market during 2025-2032. However, the high costs associated with organ-on-a-chip systems may hamper market growth to some extent during the forecast years.